Jonathan S. Mill

328 papers receiving 39k citations

Jonathan S. Mill's Hit Papers

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS 2022 · 631 citations
6310+5+11Years since publication5001k1.5k2k

Peers

Jonathan S. Mill
Comparison fields: 5 of 188
  • Behavioral Neuroscience 1.6k
  • Biological Psychiatry 448
  • Psychiatry and Mental health 5.9k
  • Cellular and Molecular Neuroscience 4.2k
  • Clinical Psychology 5.5k
Replace Hans Jörgen Grabe with:
Hans Jörgen Grabe Germany
Gonneke A. H. M. Willemsen Netherlands
Bertram Müller-Myhsok Germany
Jouke‐Jan Hottenga Netherlands
Naomi R. Wray Australia
Gerome D. Breen United Kingdom
Cathryn M. Lewis United Kingdom
Johannes Kornhuber Germany
Dick Frans Swaab Netherlands
Andrew Mark McIntosh United Kingdom
Jonathan S. Mill relative to Hans Jörgen Grabe Germany Hans Jörgen Grabe's profile →
Citations per field
00.5×2×2.6×
Hans Jörgen Grabe · 1×
Citations per year

Countries citing papers authored by Jonathan S. Mill

Since Specialization
Citations

This map shows the geographic impact of Jonathan S. Mill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan S. Mill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan S. Mill more than expected).

Fields of papers citing papers by Jonathan S. Mill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan S. Mill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan S. Mill. The network helps show where Jonathan S. Mill may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan S. Mill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan S. Mill Line = papers co-authored together Jonathan S. Mill links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 336 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene
Hit paper breakdown →
20036281
2
Role of Genotype in the Cycle of Violence in Maltreated Children
Hit paper breakdown →
20023391
3
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
Hit paper breakdown →
20182227
4
Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Hit paper breakdown →
20111510
5
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia
Hit paper breakdown →
2020897
6
A data-driven approach to preprocessing Illumina 450K methylation array data
Hit paper breakdown →
2013835
7
Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci
Hit paper breakdown →
2014765
8
Epigenomic Profiling Reveals DNA-Methylation Changes Associated with Major Psychosis
Hit paper breakdown →
2008647
9
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Hit paper breakdown →
2022631
10
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Hit paper breakdown →
2009584
11
Epigenome-Wide Scans Identify Differentially Methylated Regions for Age and Age-Related Phenotypes in a Healthy Ageing Population
Hit paper breakdown →
2012579
12 2012559
13
Genome-Wide Analyses Identify KIF5A as a Novel ALS Gene
Hit paper breakdown →
2018539
14
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
Hit paper breakdown →
2014462
15
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Hit paper breakdown →
2020457
16
Quantification of the pace of biological aging in humans through a blood test, the DunedinPoAm DNA methylation algorithm
Hit paper breakdown →
2020447
17
Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
Hit paper breakdown →
2020415
18 2012389
19 2011375
20 2015358

About Jonathan S. Mill

Jonathan S. Mill is a scholar working on Psychiatry and Mental health, Molecular Biology, Genetics, Neurology and Physiology, having authored 336 papers that have together received 40.7k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (174 papers), Attention Deficit Hyperactivity Disorder (39 papers), Schizophrenia research and treatment (29 papers), Alzheimer's disease research and treatments (28 papers), Genetic Associations and Epidemiology (25 papers), Amyotrophic Lateral Sclerosis Research (21 papers), Dementia and Cognitive Impairment Research (20 papers) and Autism Spectrum Disorder Research (17 papers). The work is most often cited by research in Behavioral Neuroscience (1.6k citations), Biological Psychiatry (448 citations), Psychiatry and Mental health (5.9k citations), Cellular and Molecular Neuroscience (4.2k citations) and Clinical Psychology (5.5k citations). Jonathan S. Mill has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Ian Craig, Avshalom Caspi, Terrie E. Moffitt, Richie Poulton, Joseph L. McClay, Judy Martin, Leonard C. Schalkwyk, Karen Sugden, Antony W. Braithwaite and HonaLee Harrington. Their work appears in journals such as Molecular Psychiatry, Nature Communications, Translational Psychiatry, American Journal of Medical Genetics Part B Neuropsychiatric Genetics and Epigenetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact